Unlocking the Secrets of Lifespan Extension with Karl Pfleger

This week, we speak with Karl Pfleger, PhD who, after studying
Machine Learning at Stanford and working a successful tech
career, now does all he can to support longevity research and
biotech. Karl discusses the inadequacies of traditional
healthcare in addressing the root causes of aging and shares
insights on groundbreaking research that can slow down or even
reverse aging processes. He emphasizes the significant impact of
lifestyle choices on longevity and previews promising future
therapies, including stem cell treatments and mitochondrial
health interventions.

What kind of SuperAger are you? Check the SuperAge Quiz
and find out! (visit: ageist.com/quiz)

Thanks to our sponsors:
InsideTracker – the dashboard to your Inner Health. Listeners
get 20% off on all products at InsideTracker.com/AGEIST.

Timeline Nutrition — our favorite supplement for cell
support and mitochondrial function. Listeners receive 10% off
your first order of Mitopure with code AGEIST at
TimelineNutrition.com/ageist.

AmeriCorps Seniors — Get involved in your community
through AmeriCorps Seniors’ volunteer opportunities and change
your life. Go to AmeriCorps.gov/YourMoment 





Key Moments“So the traditional health care and
medical practice in our country, in the US and most of the world
concerns really considering everyone to be baseline healthy until
they get sick to a level where they're very sick and they cross
some kind of a threshold for diagnosis of having an actual
disease. So even though we call it health care, a lot of people
kind of pejoratively describe it as sick care.”

“In short-lived species you can extend lifespans manyfold. One
single gene mutation in worms can extend their lifespans by 10X,
for example. And even in mice, we have interventions now that can
extend their lifespans by 30% or 40% sometimes. And many of these
interventions work across multiple species. So we believe they’re
likely to work for people as well."

“I wanted them to realize how big [the longevity field] had
gotten so that they wouldn't delay getting into it with more
serious amounts of money. They didn't realize that they were two
years behind given how fast it was growing.”





Connect with Karl
PflegerXAgingBiotech.info
LinkedIn


Say hi to the AGEIST team!